1Kisli E,Baser M,Aydin M,et al.The role of octreotide versusplacebo in the prevention of post-ERCP pancreatitis.Hepato-gastroenterology,2007,54(73):250-253.
4Dickinson RJ,Davies S.Post-ERCP pancreatitis and hyperamy-lasaemia:the role of operative and patient factors.Eur J Gas-troenterol Hepatol,1998,10:423-428.
5Johnson GK,Geenen JE,Johnson JF,et al.Evaluation of post-ERCP pancreatitis:potential causes noted during controllesstudy of differing contrast media:Midwest PancreaticobiliaryStudy Group.Gastrointest Endosc,1997,46:217-222.
1Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc ,2001,54:425-434.
2Poon RT, Yeung C, Lo CM, et al. Prophylactic effect of somatostatin on post-ERCP pancreatitis:a randomized controlled trial. Gastrointest Endosc, 1999,49: 593 -598.
3Cotton PB, Lehman G, Yennes J, et al. Endoscopic sphincterotomy complications and their management:an attempt at consensus. Gastrointest Endosc, 1991,37:383-393.
4Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc, 1998,48:1-10.
5Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP:a prospective multicenter study. Am J Gastroenterol,2001,96 :417-423.
6Manolakopoulos S, Avgerinos A, Vlachogiannakos J, et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc ,2002,55:470-475.
7Freeman ML. Precut (access) sphincterotomy. Techniques in Gastrointest Endoscopy, 1999,1:40-48.
8Cotton PB. Precut papillotomy: a risky technique for experts only.Gastrointest Endosc, 1989,35:578-579.
